Literature DB >> 9549817

Incomplete quality of life data in randomized trials: missing forms.

D Curran1, G Molenberghs, P M Fayers, D Machin.   

Abstract

Analysing quality of life (QOL) data may be complicated for several reasons, such as: repeated measures are obtained; data may be collected on ordered categorical responses; the instrument may have multidimensional scales, and complete data may not be available for all patients. In addition, it may be necessary to integrate QOL with length of life. The major undesirable effects of missing data, in QOL research, are the introduction of biases due to inadequate modes of analysis and the loss of efficiency due to reduced sample sizes. Currently, there is no standard method for handling missing data in QOL studies. In fact, there are very few references to methods of handling missing data in this context. The aim of this paper is to provide an overview of methods for analysing incomplete longitudinal QOL data which have either been presented in the QOL literature or in the missing data literature. These methods of analysis include complete case, available case, summary measures, imputation and likelihood-based approaches. We also discuss the issue of bias and the need for sensitivity analyses.

Entities:  

Mesh:

Year:  1998        PMID: 9549817     DOI: 10.1002/(sici)1097-0258(19980315/15)17:5/7<697::aid-sim815>3.0.co;2-y

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  23 in total

Review 1.  Quality of life assessment in surgical oncology trials.

Authors:  Kerry Avery; Jane M Blazeby
Journal:  World J Surg       Date:  2006-07       Impact factor: 3.352

2.  Missing data imputation in quality-of-life assessment: imputation for WHOQOL-BREF.

Authors:  Ting Hsiang Lin
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

3.  Quality of life of palliative chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction treated with irinotecan combined with 5-fluorouracil and folinic acid: results of a randomised phase III trial.

Authors:  Desmond Curran; Carmelo Pozzo; Jerzy Zaluski; Magdalena Dank; Carlo Barone; Vahur Valvere; Suayib Yalcin; Christian Peschel; Miklós Wenczl; Erdem Goker; Roland Bugat
Journal:  Qual Life Res       Date:  2009-07-01       Impact factor: 4.147

4.  Measures of relative importance for health-related quality of life.

Authors:  Tolulope T Sajobi; Lisa M Lix; Ian Clara; John Walker; Lesley A Graff; Patricia Rawsthorne; Norine Miller; Linda Rogala; Rachel Carr; Charles N Bernstein
Journal:  Qual Life Res       Date:  2011-04-24       Impact factor: 4.147

5.  Longitudinal Quality-of-Life Analysis of RTOG 94-05 (Int 0123):A Phase III Trial of Definitive Chemoradiotherapy for Esophageal Cancer.

Authors:  Lisa A Kachnic; Kathryn Winter; Todd Wasserman; David Kelsen; Robert Ginsberg; Thomas M Pisansky; James Martenson; Ritsuko Komaki; Gordon Okawara; Seth A Rosenthal; Christopher G Willett; Bruce D Minsky
Journal:  Gastrointest Cancer Res       Date:  2011-03

6.  Incidence of treated cardiac arrest in hospitalized patients in the United States.

Authors:  Raina M Merchant; Lin Yang; Lance B Becker; Robert A Berg; Vinay Nadkarni; Graham Nichol; Brendan G Carr; Nandita Mitra; Steven M Bradley; Benjamin S Abella; Peter W Groeneveld
Journal:  Crit Care Med       Date:  2011-11       Impact factor: 7.598

7.  Validity and reliability of the Short Form 36 Health Surveys (SF-36) among patients with spondyloarthritis in Singapore.

Authors:  Yu Heng Kwan; Warren Weng Seng Fong; Nai Lee Lui; Si Ting Yong; Yin Bun Cheung; Rahul Malhotra; Truls Østbye; Julian Thumboo
Journal:  Rheumatol Int       Date:  2016-09-23       Impact factor: 2.631

Review 8.  Patient-reported outcomes and survivorship in radiation oncology: overcoming the cons.

Authors:  Farzan Siddiqui; Arthur K Liu; Deborah Watkins-Bruner; Benjamin Movsas
Journal:  J Clin Oncol       Date:  2014-08-11       Impact factor: 44.544

9.  Patterns over time in quality of life, coping and psychological adjustment in late stage melanoma patients: an application of multilevel models.

Authors:  J E Brown; M T King; P N Butow; S M Dunn; A S Coates
Journal:  Qual Life Res       Date:  2000-02       Impact factor: 4.147

Review 10.  Patient reported endpoints for measuring clinical benefit in (high grade glioma) primary brain tumor patients.

Authors:  Terri S Armstrong; Mark R Gilbert
Journal:  Curr Treat Options Oncol       Date:  2014-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.